Possibilities & Pitfalls: Reimbursement and Regulatory Issues - McDermott Skip to main content

Possibilities and Pitfalls: Reimbursement and Regulatory Issues

Overview



Access the takeaways here.

Through the groundbreaking creation and rapid development of cutting-edge diagnostic and treatments solutions that significantly improve patient outcomes for cancer and other conditions, precision medicine has, and will continue to, dramatically transform healthcare.

Effective partnerships and other collaborations have become essential to advancing the new approaches precision health offers. In the second program of our Precision Health series, our panelists will use real-world scenarios to explore:

  • The strategic, financial, legal and regulatory compliance challenges that arise in the formation and implementation of such partnerships and other collaborations, including privacy, fraud and abuse, and reimbursement regulatory challenges, and
  • Alternative strategies for managing such challenges at the formation stage and throughout the lifecycle of both the collaboration and the particular innovation on which the collaboration is focused

Dig Deeper

London / In-person / September 24, 2026

HPE Europe 2026

Brussels, Belgium / Speaking Engagements / May 21, 2026

EU Pharmaceutical Law Forum 2026

Nashville, TN / In-person / May 20 - 21, 2026

McDermott HealthEx 2026

Chicago, IL / Speaking Engagements / April 30 – May 1, 2026

17th Annual Advanced Forum on Managed Care Disputes and Litigation

San Francisco, CA / In-person / April 30, 2026

Health Tech Investment Forum 2026

Las Vegas, NV / Speaking Engagements / April 26 – April 30, 2026

Asembia’s AXS26 Summit

Get In Touch